Outlook Therapeutics Inc

Officers & Directors

C. Russell Trenary III - Name,

Outlook Therapeutics Inc currently has 17 employees.

News about Outlook Therapeutics Inc Key Personnel

Leadership Change at Outlook Therapeutics: Navigating Challenges Amidst Regulatory Milestones

In a notable shift within its leadership, Outlook Therapeutics Inc. has appointed Faisal G. Sukhtian as Chairman of the Board of Directors as of January 31, 2025. Sukhtian steps into the role formerly held by Randy Thurman, who will continue to support the company as Lead Independent Director. This transition comes at a pivotal time for Outlook Therapeutics, a biopharmaceutical firm that recently celebrated a significant milestone with the European Union and the United Kingdom granting regulatory approval for the first authorized use of an ophthalmic formulation of bevacizumab, specifically designed to treat wet age-related macular degeneration (wet AMD).Despite this promising development, Outlook Therapeuti...

Business Description

Officers & Directors

OTLK Management Effectiveness

OTLK Revenue per Employee

OTLK Income per Employee

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.